Water-soluble associative amphoteric polymer as a rheology modifier for subterranean treatments
US-2024199939-A1 · Jun 20, 2024 · US
US10059869B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10059869-B2 |
| Application number | US-201415035977-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 20, 2014 |
| Priority date | Feb 20, 2014 |
| Publication date | Aug 28, 2018 |
| Grant date | Aug 28, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method comprises obtaining or providing a treatment fluid comprising a viscosifier polymer; an aqueous carrier fluid comprising high total dissolved solids; and a polymer composition comprising at least one of polyvinyl alcohol and polylactic acid. In some embodiments, the treatment fluid has a viscosity at 140C and at a shear rate of about 0.1 s−1 to about 1 s−1 of about 1,500 cP to about 10,000 cP. The method includes placing the treatment fluid in a subterranean formation.
Opening claim text (preview).
What is claimed is: 1. A method comprising: placing in a subterranean formation a treatment fluid comprising: a viscosifier polymer; a first aqueous carrier fluid comprising first total dissolved solids in a range from about 50,000 mg/L to about 200,000 mg/L; a polymer composition comprising a second aqueous carrier fluid and at least one of polyvinyl alcohol or polylactic acid, wherein the second aqueous carrier fluid comprises second total dissolved solids in a range from about 20,000 mg/L to about 250,000 mg/L; and wherein the treatment fluid has a viscosity at 140° F. and at a shear rate of about 0.1 s −1 to about 1,000 s −1 of about 30 cP to about 10,000 cP, and contains about 0.5 pptg to about 10 pptg of at least one of polyvinyl alcohol or polylactic acid. 2. The method of claim 1 , wherein the polyvinyl alcohol comprises a polyvinyl alcohol homopolymer. 3. The method of claim 1 , wherein the polyvinyl alcohol is about 80% to about 100% hydrolyzed. 4. The method of claim 1 , wherein the polyvinyl alcohol comprises a structure of the formula: wherein R 1 is hydrogen or a C 1 -C 30 hydrocarbyl group; and n is an integer from about 1,000 to about 10,000. 5. The method of claim 1 , wherein the polylactic acid comprises a polylactic acid homopolymer. 6. The method of claim 1 , wherein the polylactic acid comprises a structure of the formula: wherein R 1 is hydrogen or a C 1 -C 30 hydrocarbyl group; and p is an integer from about 600 to about 7,000. 7. The method of claim 1 , wherein the polyvinyl alcohol has a molecular weight of about 500 g/mol to about 200,000 g/mol. 8. The method of claim 1 , wherein polylactic acid has a molecular weight of about 1,000 g/mol to about 150,000 g/mol. 9. The method of claim 1 , wherein the treatment fluid comprises a fracturing fluid, remedial treatment fluid or stimulation fluid. 10. The method of claim 1 , wherein the treatment fluid comprises a fracturing fluid. 11. The method of claim 1 , wherein the viscosifier polymer comprises at least one of polyacrylamides; hydrolyzed polyacrylamides; xanthan; scleroglucan; cellulose; carboxymethylhydroxymethyl cellulose; carboxymethylhydroxyethyl cellulose; polysaccharides; amphoteric polymers made from at least one of acrylamide, acrylic acid, or diallyldimethylammonium chloride; vinyl sulfonate/vinyl amide/acrylamide terpolymers; vinyl sulfonate/acrylamide copolymers; acrylamide/acrylamido-methylpropanesulfonic acid copolymers; acrylamide/vinylpyrrolidone copolymers; sodium carboxymethyl cellulose; acrylamide/octadecyldimethylammoniummethyl methacrylate bromide copolymer; dimethylaminoethyl; methacrylate/vinyl pyrrolidone/hexadecyldimethylammoniumethyl methacrylate bromide terpolymer; or acrylamide/2-acrylamido-2-methyl propane sulfonic acid/2-ethylhexyl methacrylate terpolymer. 12. The method of claim 1 , wherein the first aqueous carrier fluid comprises at least one of seawater, produced water, flowback water, or saltwater. 13. The method of claim 1 , wherein the first total dissolved solids is in a range from about 100,000 mg/L to about 200,000 mg/L. 14. The method of claim 1 , wherein the treatment fluid further comprises a crosslinking agent comprising at least one of chromium, aluminum, antimony, zirconium, titanium, calcium, boron, iron, silicon, copper, zinc, magnesium, or an ion thereof. 15. The method of claim 1 , wherein the treatment fluid has a pH of from about 7.5 to about 10. 16. The composition of claim 1 , wherein the treatment fluid has a viscosity at 140° C. and at a shear rate of about 0.1 s −1 to about 100 s −1 of about 2,000 cP to about 5,000 cP. 17. The method of claim 1 , further comprising: combining the viscosifier polymer and the aqueous carrier fluid to produce a viscosifier polymer composition; and combining the polymer composition and the viscosifier polymer composition to produce the treatment fluid.
Surface-active agents, dispersants · CPC title
containing hydraulic cements other than calcium sulfates · CPC title
Water-loss or fluid-loss reducers, hygroscopic or hydrophilic agents, water retention agents · CPC title
Fiber-containing well treatment fluids · CPC title
containing cross-linking agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.